• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Insite Vision Inc

+ Add to Watchlist

INSV:US

0.2800 USD 0.0200 6.67%

As of 20:10:00 ET on 08/27/2014.

Snapshot for Insite Vision Inc (INSV)

Open: 0.3000 Day's Range: 0.2776 - 0.3000 Volume: 72,158
Previous Close: 0.3000 52wk Range: 0.1000 - 0.3500 1-Yr Rtn: +40.00%

Stock Chart for INSV

No chart data available.
  • INSV:US 0.2800
  • 1D
  • 1M
  • 1Y
0.3000
Interactive INSV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 1.5556
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.0656
Est. EPS (USD) (12/2014) 0.1800
Est. PEG Ratio -
Market Cap (M USD) 36.95
Shares Outstanding (M) 131.95
30 Day Average Volume 71,458
Price/Book (mrq) -
Price/Sale (ttm) 2.6726
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSV

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Timothy M RuaneChief Executive OfficerKamran HosseiniChief Medical Officer
Louis C DrapeauVP/CFOLyle M BowmanVP:Development/Secretary
More Company Profile & Key Executives for INSV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil